BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7482911)

  • 1. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of donor age on kidney graft function and on histopathological findings.
    Isoniemi H; von Willebrand E; Krogerus L; Taskinen E; Ahonen J; Häyry P
    Transplant Proc; 1992 Feb; 24(1):328-9. PubMed ID: 1539296
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple-drug regimen for first kidney transplants in developing countries.
    Erken U; Erken E; Tansuğ Z; Türkyilmaz R
    Transplant Proc; 1992 Oct; 24(5):1843. PubMed ID: 1412875
    [No Abstract]   [Full Text] [Related]  

  • 4. Cadaveric renal transplantation: multifactorial analysis of possible causes affecting graft outcome in recipients treated with and without cyclosporine.
    Isa WA; Robles JE; Rosell D; Aguera LG; de Castro F; Sanchez PL; Zudaire JJ; Errasti P; Berian JM
    Transplant Proc; 1992 Feb; 24(1):115-7. PubMed ID: 1539200
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical usefulness of conventional fine needle aspiration cytology in kidney transplantation--influence of different immunosuppressive protocols.
    Almirall J; Sole M; Campistol JM; Muntane J; Bru C; Oppenheimer F; Andreu J; Revert L
    Transplant Proc; 1992 Feb; 24(1):71-2. PubMed ID: 1539350
    [No Abstract]   [Full Text] [Related]  

  • 6. Live donor renal transplantation with low-dose triple immunosuppression.
    Francis DM; Millar RJ; Walker RG; Nicholls K; Powell H; Jones C; Kockelbergh R; Becker G
    Transplant Proc; 1992 Oct; 24(5):2243. PubMed ID: 1413041
    [No Abstract]   [Full Text] [Related]  

  • 7. First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1992 Oct; 24(5):2241-2. PubMed ID: 1413040
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant neoplasms in renal transplant patients: a 24-year experience.
    Bordes-Aznar J; Mancilla E; Rosenblum M; Gabilondo F; Orozco R; Angeles A; Alberú J
    Transplant Proc; 1992 Oct; 24(5):1802-3. PubMed ID: 1412851
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-year results of a prospective randomized comparison of cyclosporine/low dose steroid immunosuppression with azathioprine and steroids in renal transplantation.
    Mieny CJ; Nel PJ; Becker JH; Pretorius JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1852. PubMed ID: 3079049
    [No Abstract]   [Full Text] [Related]  

  • 10. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
    Schweizer RT; Rovelli M; Roper L; Bartus SA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results with conversion from cyclosporine to azathioprine at 3 months after renal transplantation.
    Ovnat A; Pontin AR; Cassidy MJ; Swanepoel CR; Kahn D
    Transplant Proc; 1992 Oct; 24(5):1698-9. PubMed ID: 1412802
    [No Abstract]   [Full Text] [Related]  

  • 12. CyA monotherapy in patients over 50 years of age after renal transplantation: short-term results.
    Morales JM; Sancho S; Muñoz Cepeda MA; Andres A; Campo C; Alcazar JM; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):37-8. PubMed ID: 1539322
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of three immunosuppressive protocols in patients aged over 50 years.
    Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
    [No Abstract]   [Full Text] [Related]  

  • 14. Is cyclosporine indicated in HLA-identical renal transplant recipients?
    Sumrani N; Delaney V; Ding Z; Davis R; Butt K; Hong J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in immunosuppression for kidney transplantation.
    Butt KM; Zielinski CM; Parsa I; Elberg AJ; Wechter W; Kountz SL
    Kidney Int Suppl; 1978 Jun; (8):S95-8. PubMed ID: 357820
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal transplantation in cyclosporine-treated patients over age 50.
    Riera L; Serón D; Castelao AM; Griñó JM; Franco E; Bover J; Vigués L; Alsina J; Serrallach N
    Transplant Proc; 1992 Feb; 24(1):122-3. PubMed ID: 1539204
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunosuppressive therapy].
    Nakamura H
    Rinsho Byori; 1991 Jul; Suppl 90():102-14. PubMed ID: 1920848
    [No Abstract]   [Full Text] [Related]  

  • 18. Living related donor kidney transplantation at a Turkish center.
    Hamaloğlu E; Tokyay R; Arslan G; Bilgin N; Büyükpamukçu N; Haberal M
    Transplant Proc; 1992 Oct; 24(5):1848-9. PubMed ID: 1412878
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined immunosuppression (cyclosporin, azathioprine, methylprednisolone) in patients at immunological risk after kidney transplantation].
    Hillebrand G; Castro LA; Illner WD; Schleibner S; Land W; Gurland HJ
    Z Urol Nephrol; 1985 Dec; 78(12):667-71. PubMed ID: 3913221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living related donor renal transplantation in Semarang, Indonesia (1985 to 1991).
    Shofa C; Soewito A; Darmono E; Hendro W; Lysiani S; Purwanto ; Chandra M; Faik H; Rifki M; Parsudi AI
    Transplant Proc; 1992 Oct; 24(5):1813. PubMed ID: 1412858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.